The company took stock of the work in the first three quarters to encourage the completion of the annual target.
Release time:
2020-10-23
Company takes stock of the work in the first three quarters
to encourage
to achieve the annual target. News from our newspaper 10# August 19 and 20 , the company held a third quarter business work analysis meeting to comprehensively review, summarize and analyze the work of each business sector in the first three quarters of 2020 to find problems, to find a way to do a good job in the fourth quarter and fully complete the work objectives set at the beginning of the year. At the
analysis meeting, the heads of each subordinate business section reported on the work in the first three quarters, focusing on analyzing the existing problems and proposing solutions and improvement plans. Chairman Jiang Xiaomeng, general manager Yu Jianhong and other group company leaders commented on the work, pointed out the highlights, and analyzed the problems and deficiencies in the light of the operating data of various enterprises. As the future API R & D and production base of Jianfeng Pharmaceutical, North Carolina received "special treatment" this quarter, and the company held a special meeting to "prescribe the pulse" for the company's future business development ".
International Trade Company: Strengthen the standard, reduce the operating cost and speed up the platform construction
Conference pointed out that in recent years, Jianfeng International Trade Company has accelerated the business transformation, market expansion and strengthened the management standardization construction, and made certain progress, but there is still a gap with the target requirements of the group company. With the change of the business model and enterprise scale, we should further achieve breakthroughs from the following aspects as soon as possible: further sort out and standardize the work process, reduce unnecessary management links, strengthen the sense of responsibility and cost control, and reduce the overall operating cost; From the image of the park, business process to internal assessment, we should do a good job in the standardization of park management in an all-round way, and set up systems and standards based on the existing business requirements to ensure that the standards are practical, the work process is efficient and the responsibilities are clear; strengthen the cultivation of new markets and new businesses, strengthen the introduction of futures delivery products, and improve profitability; accelerate the construction of third-party freight platforms to attract upstream and downstream customers and freight resources; strengthen the construction progress, cost, construction quality and safety management of new warehouses to ensure Early use; strengthen the maintenance of the original warehouse; pay attention to international and domestic economic trends and RMB exchange rates to avoid exchange risks; safety as the first premise to carry out the operation and management work.
Cable Company: Reduce costs, improve capabilities, seize opportunities
Cable Company has clear working ideas and bright spots in team building, which has been unanimously affirmed by the leaders of the Group Company. The meeting required Jianfeng Cable Company to further improve its production and quality management capabilities, improve production and quality control standards, strive to improve product qualification rates, reduce production costs, and enhance the company's response to market changes in response to the current multi-variety, multi-specification, and small-batch business model; further improve the market model, sales model, and business undertaking model to enhance profitability; strengthen the acquisition of access qualifications for various specialized industries, improve the ability to undertake business; seize the current opportunities to strengthen urban rail and subway transportation construction in various places, create the image of specialized cable manufacturers, and seek market breakthroughs.
Health Technology Company: Clarify the thinking, grasp the key points and improve the efficiency
Meeting requires the management team of Jianfeng Health Technology Company to carefully clarify the thinking and define the development direction; Carefully sort out and analyze the existing product lines, focus on key products with strong profitability, and do a good job in quality management and market development; Clear product development ideas and introduce competitive products for the future market; do a good job of inventory management and fund management, further optimize and refine management, improve the overall efficiency of the enterprise.
Cement Plate: Optimize Management, Improve Efficiency and Prevent Risks
In view of the common problems existing in the cement plate of the company, the meeting requires all cement enterprises to strengthen the application of informatization and intelligence, optimize and adjust the organizational structure, further improve the management efficiency and enterprise operation efficiency according to their own reality and the overall development of the cement industry. Further improve the internal responsibility assessment, to achieve clear and concise work process and post responsibilities; To set standards for advanced enterprises, strengthen technological transformation and innovation, and improve the reliability of equipment operation; Strengthen environmental protection management requirements and on-site renovation, and create civilized and sanitary factories; Around the annual target, force all work links to ensure that production management, quality management and cost control are in place; Improve sales capacity, grasp the core regional market and expand the key project market; strengthen learning through various forms and ways, learn from internal and external experiences and lessons, and improve the overall quality and skill level of the team; according to the current economic environment, there are many uncertain factors and the increasingly fierce competition in the cement industry, do a good job in preventing possible market risks and do a good job in the corresponding market convergence. The
meeting also required Daye Peak and Yunnan Peak to make preparations for the next technological transformation. Huang Ping Peak is required to strengthen on-site renovation, strengthen team building, and achieve production standards and production and sales balance as soon as possible.
Pharmaceutical Sector: Strengthen Responsibility, Improve Execution, Innovate Thinking, Improve Efficiency
Meeting Requires Managers at All Levels of Jianfeng Pharmaceutical Company to Strengthen Responsibility and Responsibility Awareness, Build Confidence, Effectively Improve Execution, Deal with Changes and Difficulties Brought by Various Uncertain Factors with Courage and Wisdom, and Fundamentally Solve the "Short Board" Problem in Enterprises; Deal with the Market with Innovative Thinking, improve the market response ability, market planning ability and market system control ability, straighten out the existing market order, clarify the market performance of each product, and plan and promote the listing of new products in more scientific and effective ways and methods; do a good job in improving work Efficiency is a big article, through informatization, intelligent construction and management system optimization, reasonable organization and arrangement of personnel to improve overall efficiency; strengthen the innovation of internal production management and process technology; speed up the progress of product research and development and launch, while strengthening the construction of its own R & D platform and R & D team, improve the control ability of cooperative development of products; strengthen cost control from all production links for the lowest cost of standard and quality products; strengthen the management of various technological transformation and speed up the construction of international projects; Pharmaceutical business should build confidence and strengthen the improvement of internal management, timely grasp and seize opportunities, control costs, play their own advantages.
In view of the current business situation of North Carolina, the meeting asked the management team of North Carolina to earnestly understand the current situation of the market and competitors, further clarify the positioning and development direction of the enterprise, establish confidence, and find and solve the current problems from the perspective of future development. Make careful calculations from each business link to establish comparative advantages in technology and technology; Fully introduce the cost-leading force mechanism, comprehensively improve the management level through intelligent and information construction, reduce various management and production costs; starting from the advantages of the company's technology, process, scale, and resource matching, scientifically select and develop products, and do a good job in innovative drugs and innovative products Research and development; do a good job in resource integration among subordinate enterprises to improve labor productivity. (this newspaper reporter)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31